CompoAtlas

glandline HAIRLUX

Food supplement declared in France, decision dated 27 May 2026

glandline HAIRLUX, from SENSILAB Ltd., is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Adiantum capillus-veneris 150 mg per day, Pisum sativum 100 mg per day, Vaccinium myrtillus 10 mg per day, Biotin (vitamin B8), Copper. None of the rules we check flags an issue with its declared composition; vitamin and mineral doses are not published by Compl'Alim and are therefore not checked.

Brand
not provided
Food business operator placing the product on the market
SENSILAB Ltd.
Status
Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
Form
Capsule
Daily dose
2 GÉLULES

Declaration 366068, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.

Declared composition

Plants

PlantPartPreparationPer day
Adiantum capillus-veneris L.Parties aériennesExtrait sec aqueux150 mg
Pisum sativum L.GermeExtrait sec aqueux100 mg
Vaccinium myrtillus L.FruitExtrait sec aqueux10 mg

Other active ingredients

NamePer day
Chlorhydrate de L-cystéinenot declared
Méthioninenot declared

Vitamins and minerals

Compl'Alim does not publish vitamin and mineral doses. The references below help you read the product label: EFSAEuropean Food Safety Authority. safety limit for adults and maximum dose set in France per product (Order of 9 May 2006, not revised since November 2006).

Declared formNutrientEFSA limit, adults Maximum dose in France
D-biotinBiotin (vitamin B8)no limit (insufficient data)dose annulled by the French Council of State in 2011
cupric citrateCopper5,000 µg2,000 µg
L-selenomethionineSelenium255 µg50 µg
pyridoxal 5′-phosphateVitamin B612 mg2 mg
zinc bisglycinateZinc25 mg15 mg

Additives

E460, E464, E414

List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).

Has the product changed? Photograph the packaging.

Regulatory points

None of the rules we check applies to the declared ingredients.

This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • Vaccinium myrtillus L.
    Read the warning, when it applies and the studies cited

    BILBERRY - VACCINIUM MYRTILLUS - Buccal

    Route of administration: Buccal (Blumenthal et al. 2000)

    Cautions and warnings

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Health Canada monograph dated 30 January 2026

    BILBERRY - VACCINIUM MYRTILLUS - Oral

    Route of administration: Oral (Blumenthal et al. 2000)

    Cautions and warnings

    Condition of application: Relief of diarrhea.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms persist or worsen.

    Condition of application: Slowing the progression of disorders of the eye and to relieve symptoms related to non-complicated CVI.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician if symptoms worsen.

    Health Canada monograph dated 25 October 2024

They concern the ingredient, not this product or its dose. They do not replace medical advice.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Cite this page: CompoAtlas, “glandline HAIRLUX: composition and regulation”, https://compoatlas.com/en/supplements/products/366068-glandline-hairlux, updated 15 November 2026.

Enter to analyse, Shift+Enter for a new line